Michael D. West
2017 - BioTime
In 2017, Michael D. West earned a total compensation of $1.6M as Former Co, Chief Executive Officer at BioTime.
Compensation breakdown
| Bonus | $65,000 |
|---|---|
| Option Awards | $865,720 |
| Salary | $680,315 |
| Other | $13,500 |
| Total | $1,624,535 |
West received $865.7K in option awards, accounting for 53% of the total pay in 2017.
West also received $65K in bonus, $680.3K in salary and $13.5K in other compensation.
Rankings
In 2017, Michael D. West's compensation ranked 6,572nd out of 14,666 executives tracked by ExecPay. In other words, West earned more than 55.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,572 out of 14,666 | 55th |
Division Manufacturing | 2,430 out of 5,770 | 58th |
Major group Chemicals And Allied Products | 780 out of 2,074 | 62nd |
Industry group Drugs | 602 out of 1,730 | 65th |
Industry Biological Products, Except Diagnostic Substances | 109 out of 316 | 66th |
Source: SEC filing on June 14, 2019.
West's colleagues
We found three more compensation records of executives who worked with Michael D. West at BioTime in 2017.
News
AgeX Therapeutics CEO Michael West's 2020 pay falls 46% to $561K
November 24, 2021
AgeX Therapeutics CEO Michael West's 2019 pay falls 24% to $1M
November 24, 2020
AgeX Therapeutics CEO Michael West's 2018 pay rises 2% to $1.7M
November 29, 2019
BioTime CEO Brian Culley's 2018 pay jumps 75% to $2.8M
June 14, 2019